Description

Procedure for identifying, evaluating, and implementing changes published in official pharmacopoeias (e.g., USP, EP, BP, JP, IP) to ensure continuous compliance of materials, products, and analytical methods.This procedure applies to all active pharmaceutical ingredients (APIs), excipients, primary packaging materials, and finished products.